Autoimmune Hemolytic Anemia Therapeutics Market by Product and Geography - Global Forecast & Analysis 2019-2023

SKU ID : TNV-14050732

No. of pages : 150

Publishing Date : 01-Oct-2019

Detailed TOC of Autoimmune Hemolytic Anemia Therapeutics Market by Product and Geography - Global Forecast & Analysis 2019-2023

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Corticosteroids - Market size and forecast 2018-2023

Monoclonal antibodies - Market size and forecast 2018-2023

Others - Market size and forecast 2018-2023

Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America - Market size and forecast 2018-2023

Europe - Market size and forecast 2018-2023

Asia - Market size and forecast 2018-2023

ROW - Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

R&D of novel therapeutics

Advances in murine models

Development of combination therapies

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Amneal Pharmaceuticals Inc.

Baxter International Inc.

F. Hoffmann-La Roche Ltd.

Incyte Corp.

Kezar Life Sciences Inc.

Mylan NV

Pfizer Inc.

Rigel Pharmaceuticals Inc.

Sanofi

Teva Pharmaceutical Industries Ltd.

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO





Exhibit 01: Product overview

Exhibit 02: Global pharmaceuticals market

Exhibit 03: Segments of global pharmaceuticals market

Exhibit 04: Market characteristics

Exhibit 05: Market segments

Exhibit 06: Market definition - Inclusions and exclusions checklist

Exhibit 07: Market size 2018

Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 10: Five forces analysis 2018

Exhibit 11: Five forces analysis 2023

Exhibit 12: Bargaining power of buyers

Exhibit 13: Bargaining power of suppliers

Exhibit 14: Threat of new entrants

Exhibit 15: Threat of substitutes

Exhibit 16: Threat of rivalry

Exhibit 17: Market condition - Five forces 2018

Exhibit 18: Product - Market share 2018-2023 (%)

Exhibit 19: Comparison by product

Exhibit 20: Corticosteroids - Market size and forecast 2018-2023 ($ millions)

Exhibit 21: Corticosteroids - Year-over-year growth 2019-2023 (%)

Exhibit 22: Monoclonal antibodies - Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Monoclonal antibodies - Year-over-year growth 2019-2023 (%)

Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions)

Exhibit 25: Others - Year-over-year growth 2019-2023 (%)

Exhibit 26: Market opportunity by product

Exhibit 27: Customer landscape

Exhibit 28: Market share by geography 2018-2023 (%)

Exhibit 29: Geographic comparison

Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)

Exhibit 31: North America - Year-over-year growth 2019-2023 (%)

Exhibit 32: Top 3 countries in North America

Exhibit 33: Europe - Market size and forecast 2018-2023 ($ millions)

Exhibit 34: Europe - Year-over-year growth 2019-2023 (%)

Exhibit 35: Top 3 countries in Europe

Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)

Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)

Exhibit 38: Top 3 countries in Asia

Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)

Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)

Exhibit 41: Top 3 countries in ROW

Exhibit 42: Key leading countries

Exhibit 43: Market opportunity

Exhibit 44: Impact of drivers and challenges

Exhibit 45: Vendor landscape

Exhibit 46: Landscape disruption

Exhibit 47: Vendors covered

Exhibit 48: Vendor classification

Exhibit 49: Market positioning of vendors

Exhibit 50: Amneal Pharmaceuticals Inc. - Vendor overview

Exhibit 51: Amneal Pharmaceuticals Inc. - Business segments

Exhibit 52: Amneal Pharmaceuticals Inc. - Organizational developments

Exhibit 53: Amneal Pharmaceuticals Inc. - Segment focus

Exhibit 54: Amneal Pharmaceuticals Inc. - Key offerings

Exhibit 55: Amneal Pharmaceuticals Inc. - Key customers

Exhibit 56: Baxter International Inc. - Vendor overview

Exhibit 57: Baxter International Inc. - Business segments

Exhibit 58: Baxter International Inc. - Organizational developments

Exhibit 59: Baxter International Inc. - Segment focus

Exhibit 60: Baxter International Inc. - Key offerings

Exhibit 61: Baxter International Inc. - Key customers

Exhibit 62: F. Hoffmann-La Roche Ltd. - Vendor overview

Exhibit 63: F. Hoffmann-La Roche Ltd. - Business segments

Exhibit 64: F. Hoffmann-La Roche Ltd. - Organizational developments

Exhibit 65: F. Hoffmann-La Roche Ltd. - Geographic focus

Exhibit 66: F. Hoffmann-La Roche Ltd. - Segment focus

Exhibit 67: F. Hoffmann-La Roche Ltd. - Key offerings

Exhibit 68: F. Hoffmann-La Roche Ltd. - Key customers

Exhibit 69: Incyte Corp. - Vendor overview

Exhibit 70: Incyte Corp. - Business segments

Exhibit 71: Incyte Corp. - Organizational developments

Exhibit 72: Incyte Corp. - Key offerings

Exhibit 73: Incyte Corp. - Key customers

Exhibit 74: Kezar Life Sciences Inc. - Vendor overview

Exhibit 75: Kezar Life Sciences Inc. - Business segments

Exhibit 76: Kezar Life Sciences Inc. - Organizational developments

Exhibit 77: Kezar Life Sciences Inc. - Key offerings

Exhibit 78: Kezar Life Sciences Inc. - Key customers

Exhibit 79: Mylan NV - Vendor overview

Exhibit 80: Mylan NV - Product segments

Exhibit 81: Mylan NV - Organizational developments

Exhibit 82: Mylan NV - Geographic focus

Exhibit 83: Mylan NV - Segment focus

Exhibit 84: Mylan NV - Key offerings

Exhibit 85: Mylan NV - Key customers

Exhibit 86: Pfizer Inc. - Vendor overview

Exhibit 87: Pfizer Inc. - Business segments

Exhibit 88: Pfizer Inc. - Organizational developments

Exhibit 89: Pfizer Inc. - Geographic focus

Exhibit 90: Pfizer Inc. - Segment focus

Exhibit 91: Pfizer Inc. - Key offerings

Exhibit 92: Pfizer Inc. - Key customers

Exhibit 93: Rigel Pharmaceuticals Inc. - Vendor overview

Exhibit 94: Rigel Pharmaceuticals Inc. - Business segments

Exhibit 95: Rigel Pharmaceuticals Inc. - Organizational developments

Exhibit 96: Rigel Pharmaceuticals Inc. - Key offerings

Exhibit 97: Rigel Pharmaceuticals Inc. - Key customers

Exhibit 98: Sanofi - Vendor overview

Exhibit 99: Sanofi - Business segments

Exhibit 100: Sanofi - Organizational developments

Exhibit 101: Sanofi - Geographic focus

Exhibit 102: Sanofi - Segment focus

Exhibit 103: Sanofi - Key offerings

Exhibit 104: Sanofi - Key customers

Exhibit 105: Teva Pharmaceutical Industries Ltd. - Vendor overview

Exhibit 106: Teva Pharmaceutical Industries Ltd. - Business segments

Exhibit 107: Teva Pharmaceutical Industries Ltd. - Organizational developments

Exhibit 108: Teva Pharmaceutical Industries Ltd. - Segment focus

Exhibit 109: Teva Pharmaceutical Industries Ltd. - Key offerings

Exhibit 110: Teva Pharmaceutical Industries Ltd. - Key customers

Exhibit 111: Validation techniques employed for market sizing

Exhibit 112: Definition of market positioning of vendors



Keyplayers in Autoimmune Hemolytic Anemia Therapeutics Market by Product and Geography - Global Forecast & Analysis 2019-2023

Amneal Pharmaceuticals Inc.
Baxter International Inc.
F. Hoffmann-La Roche Ltd.
Incyte Corp.
Kezar Life Sciences Inc.
Mylan NV
Pfizer Inc.
Rigel Pharmaceuticals Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
market Reports market Reports